HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sara Galac Selected Research
Sara Galac Research Topics
Disease
11
Cushing Syndrome
11/2021 - 01/2010
5
Neoplasms (Cancer)
06/2022 - 09/2011
2
Diabetes Mellitus
03/2021 - 06/2016
2
Hyperthyroidism
11/2020 - 03/2004
2
Adrenocortical Hyperfunction (Adrenal Gland Hyperfunction)
06/2016 - 10/2007
1
Pituitary Neoplasms (Pituitary Adenoma)
01/2021
1
Paraganglioma (Paragangliomas)
04/2019
1
Pheochromocytoma
04/2019
1
Hypothyroidism
07/2018
1
Carcinoma (Carcinomatosis)
10/2015
1
Adenoma (Adenomas)
10/2015
1
Carcinogenesis
03/2012
1
Hypertension (High Blood Pressure)
09/2011
1
Hyperplasia
09/2011
1
Hyperaldosteronism (Conn Syndrome)
09/2011
1
Cat Diseases (Cat Disease)
09/2011
Drug/Important Bio-Agent (IBA)
6
Hydrocortisone (Cortisol)
FDA Link
Generic
01/2021 - 03/2004
4
Adrenocorticotropic Hormone (ACTH)
FDA Link
11/2021 - 12/2018
2
Biomarkers (Surrogate Marker)
IBA
06/2022 - 01/2021
2
trilostane
FDA Link
11/2021 - 01/2010
2
Hormones (Hormone)
IBA
11/2020 - 07/2018
2
Aldosterone
IBA
09/2011 - 01/2010
2
Renin
IBA
09/2011 - 01/2010
1
Cell-Free Nucleic Acids
IBA
06/2022
1
Aprotinin (Trasylol)
FDA Link
01/2021
1
MicroRNAs (MicroRNA)
IBA
01/2021
1
Succinate Dehydrogenase (Fumarate Reductase)
IBA
04/2019
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2019
1
Glucocorticoids
IBA
12/2018
1
Thyrotropin-Releasing Hormone (Protirelin)
FDA Link
12/2018
1
Type 2 Melanocortin Receptor
IBA
12/2018
1
Abiraterone Acetate
IBA
11/2018
1
Growth Hormone (Somatotropin)
IBA
07/2018
1
Thyroxine (Levothyroxine)
FDA Link
Generic
07/2018
1
Cystatin C
IBA
06/2016
1
somatostatin receptor type 1
IBA
10/2015
1
Messenger RNA (mRNA)
IBA
10/2015
1
Mineralocorticoids
IBA
09/2011
1
Thyroid Hormones
IBA
03/2004
1
Creatinine
IBA
03/2004
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
03/2004
Therapy/Procedure
2
Hypophysectomy
03/2021 - 10/2007
2
Adrenalectomy
08/2013 - 09/2011
2
Therapeutics
03/2012 - 09/2011
1
Aftercare (After-Treatment)
03/2004